זינט טבליות 250 מג
novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 250 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible microorganisms.
זינט טבליות 500 מג
novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 500 mg - cefuroxime
דאלאצין % 2 קרם וגינלי
pfizer pfe pharmaceuticals israel ltd - clindamycin phosphate - קרם - clindamycin phosphate 2 %w/w - clindamycin - clindamycin - treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.
דאלאצין פתילות ואגינליות
pfizer pfe pharmaceuticals israel ltd - clindamycin as phosphate - פתילות - clindamycin as phosphate 100 mg - clindamycin - clindamycin - dalacin vaginal ovules are indicated for 3-day treatment of bacterial vaginosis in non-pregnant women.
זינט תרחיף 125 מג5 מל
novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 25 mg/ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible microorganisms.
זינט תרחיף 250 מג5 מל
novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 50 mg/ml ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organism.
קטאפלם 50 מג
novartis israel ltd - diclofenac as potassium - טבליה - diclofenac as potassium 50 mg - diclofenac - diclofenac - management of pain and primary dysmenorrhea, when prompt pain relief is desired.
סטאלבו 10025200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.
סטאלבו 5012.5200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.